UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, — San Francisco, California

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myasthenia Gravis.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,?

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, conducted?

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, has 1 clinical trials on record, with 1 currently active. Their work covers Myasthenia Gravis.

Is UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, accredited by Crixeo Health?

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.